[33P]α-dATP (2′ deoxyadenosine 5′-(α-thio) triphosphate at a specific activity of >2500 Ci/mmol was purchased from Perkin Elmer and GTPγS (10 μM) and used for the mTOR and BDNF in situ hybridization studies.
Veratridine and NBQX Administration Protocol
[33P]α-dATP (2′ deoxyadenosine 5′-(α-thio) triphosphate at a specific activity of >2500 Ci/mmol was purchased from Perkin Elmer and GTPγS (10 μM) and used for the mTOR and BDNF in situ hybridization studies.
Corresponding Organization : Instituto de Salud Carlos III
Other organizations : Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Institut d'Investigacions Biomèdiques de Barcelona
Variable analysis
- Veratridine (50 μM)
- NBQX (100 μM)
- MTOR and BDNF expression
- [33P]α-dATP (2' deoxyadenosine 5'-(α-thio) triphosphate at a specific activity of >2500 Ci/mmol)
- GTPγS (10 μM)
- Positive controls: Not specified
- Negative controls: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!